The binding peptide TLTYTWS reduces angiogenesis in lung cancer models, and TM peptide inhibits tumor growth, angiogenesis, and migration in breast cancer by targeting neuropilin-1 (NRP1) receptors [112]. The gene discussed is NRP1; the disease is neoplasm.